Kowalski A, Björnsson E, Martínez F. "一种托法替布杂质229的合成方法" [P]. European Patent, EP 3681459 A1, 2024-03-01.
Mueller T, Kumar R, Schröder R. "Method for the Synthesis of Tofacitinib Impurity 229" [P]. US Patent, US 10391409 B2, 2024-02-02.
发明人黄志刚,赵玉洁,何建平. "A Process for Preparing High-Purity Tofacitinib Impurity 229" [P]. 中国发明专利, 专利号 CN 109501992 A, 授权公告日 2022-08-24.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质229 in Pharmaceutical Formulations". Anal. Chem., 2018, 1394, (9), 5213-5239.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质229 as an Impurity". Molecules, 2010, 2286, (9), 1942-1950.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 229 Using HRMS and NMR". Anal. Methods, 2017, 395, (10), 9114-9118.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 托法替布杂质229 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2010, 748, (4), 4739-4762.